Comment by epmaybe

I’m in ophthalmology where AI diagnostics have been promised for almost a decade. We have FDA approved diagnostics for diabetic retinopathy screening that has been commercially available since 2018, and papers claiming board certified ophthalmologist level classification accuracy as far back as inceptionv3. Maybe it’s just an economic barrier but these tools still haven’t made any meaningful impact in the US. Other countries without healthcare access? It’s helpful for culling the herd, but it doesn’t fix the last mile problem of what you do when you find referable disease that needs treatment.

My philosophical take: if AI can outperform the average, it’s probably a net benefit for society that I won’t have a job. Until then, I’m going to take my income and save up for an early retirement.